from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2536/-

LFCtreatmentdescriptionclass of inhibitor

-0.502

Amikacinug/mL Amikacintranslation

0.682

Cap5-10ug/mL Capreomycintranslation

1.470

Rox10-50 ug/mL Roxithromycintranslation

-0.072

SM2-5 ug/mL Streptomycintranslation

-0.774

Tet5-10 ug/mL Tetracyclinetranslation

-0.214

Rif0.2-5ug/mL Rifampicintranscription

-0.670

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.225

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.317

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.415

CPZ10-50 ug/mL Chlorpromazinerespiration

0.057

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.018

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-3.501

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.249

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.259

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.085

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.344

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.686

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.395

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.382

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.123

KCN5-20 ug/mL Potassium cyaniderespiration

0.166

NaN30.2-2 mM Sodium aziderespiration

1.504

Nigericin50 uM Nigericinrespiration

-0.504

TRC10-150 ug/mL Triclosanrespiration

-0.852

TRZ10-25 ug/mL Thioridazinerespiration

-2.007

Valinomycin0.5-10 uM Valinomycinrespiration

0.498

ZnSO42 mM ZnSO4respiration

0.177

menadione6-10 ug/mL Menadionerespiration

0.317

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.469

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.178

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.859

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.813

NRP_1Non-replicating persistence stage 1dosRassociated

0.412

Amp0.2mg/mL AmpicillincellWall

0.364

Cephalexin20-100 ug/mL CephalexincellWall

0.909

Cerulenin0.32-5 ug/mL CerulenincellWall

0.499

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.757

EMB10-20 ug/mL EthambutolcellWall

0.611

Eta12-40 ug/mL EthionamidecellWall

0.489

INH0.2-0.4 ug/mL IsoniazidcellWall

0.647

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.501

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.299

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.149

BZA0.12 mg/mL BenzamidearomaticAmides

0.122

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.338

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.174

H2O24 mM hydrogen peroxideDNAdamaging

0.297

Levo10 ug/mL LevofloxacinDNAdamaging

0.465

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.934

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.042

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.193

UVUV-irradiationDNAdamaging

0.996

ARP41-4 ug/mL Antitubercular compound ARP4?

0.158

Antimycin12.5-50 ug/mL Antimycin A?

0.620

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.178

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.222

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.738

PA8240.2-2 ug/mL PA-824?

-0.836

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.462

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.812

Verapamil50 uM Verapamil?

0.876

mercaptoethanol2 mM 2-Mercaptoethanol?

0.787

methoxatin10-20 ug/mL Methoxatin?